This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter: revenue up 40% year on year; net profit up 3.6% to Rs 746 million
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended 30 September 2026: revenue rose 40% year on year to Rs 13,444 million from Rs 9,607 million; net profit rose 3.6% to Rs 746 million from Rs 720 million. EBITDA margin fell to 19.4% from 21.2%; a Rs 132 million exceptional gain supported profit. Half-year ended 30 September 2026: consolidated revenue rose 38% year on year to Rs 25,239 million and net profit fell 29% to Rs 1,120 million.
Revenue growth helps, but modest profit growth and lower EBITDA margin may cap gains; reliance on an exceptional gain and warrant dilution add risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹1,344 Cr | ₹960.7 Cr | +39.9% |
| Operating profit | ₹74.10 Cr | ₹92.90 Cr | −20.2% |
| Profit after tax | ₹74.60 Cr | ₹72.00 Cr | +3.6% |
| EBITDA margin | 20.3% | 21.2% | −0.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.